HomeInsightsPE

Neuland Laboratories Ltd PE Ratio

Neuland Laboratories Ltd PE Ratio

stocks purchased

₹ 7.3 Cr

Volume Transacted

(Dec 9, 2024)

stocks purchased

4.3 K

Stocks Traded

(Dec 9, 2024)

Last Updated on: Dec 10, 2024

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

PE

82.8

Last updated on: Dec 10, 2024

Key Highlights

  • The P/E Ratio of Neuland Laboratories Ltd is 82.8 as of 10 Dec 9.00 AM .
  • The P/E Ratio of Neuland Laboratories Ltd changed from 52.9 on March 2019 to 27 on March 2024 . This represents a CAGR of -10.60% over 6 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 17046 as of 09 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

Company Fundamentals for Neuland Laboratories Ltd

No data available

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 17046.2

-525.05 (-2.99%)

stock direction

Last updated on: Dec 09, 2024

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Dec 202417046.2
06 Dec 202417571.25
05 Dec 202417808.6
04 Dec 202417756.9
03 Dec 202417217.85
02 Dec 202416661.15
29 Nov 202416691.4
28 Nov 202416593.85
27 Nov 202416084.4
26 Nov 202414943.1

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Neuland Laboratories Ltd8221,870
Sun Pharmaceuticals Industries Ltd384,33,368
Divis Laboratories Ltd861,58,213
Cipla Ltd251,18,663
Torrent Pharmaceuticals Ltd641,12,895
Mankind Pharma Ltd501,05,777

Key Valuation Metric of Neuland Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Neuland Laboratories Ltd

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June...

Read more

2024-08-01 00:00:00

News

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 Nov...

Read more

2024-10-18 00:00:00

News

Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter

Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended ...

Read more

2024-11-06 00:00:00

News

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and...

Read more

2024-11-06 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Neuland Laboratories Ltd

What is the current PE Ratio of Neuland Laboratories Ltd?

The Current PE Ratio of Neuland Laboratories Ltd is 82.8 as on 10 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 10 Dec 2024.

What was the PE Ratio of Neuland Laboratories Ltd last year?

The PE Ratio of Neuland Laboratories Ltd was 14.2 last year, now the PE ratio is 82.8, showing a year-on-year growth of 483.1%.

What does the PE Ratio of Neuland Laboratories Ltd indicate about its stock?

The PE Ratio of Neuland Laboratories Ltd is 82.8. This ratio indicates that investors are willing to pay 82.8 times the earnings per share for each share of Neuland Laboratories Ltd.

What is the PE Ratio Growth of Neuland Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Neuland Laboratories Ltd grew by 483.1% whereas, the EPS ratio grew by -66.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions